Cerami's New Lab Aims For Bountiful Blend Of Basic Research And Product Development

Investigations on aging lead the Long Island institute's efforts to combine the best traits of 'pure' and 'applied' research Just over a year after launch, the Picower Institute for Medical Research in Manhasset, N.Y., is gathering momentum, and confidence among institute researchers is growing. The institute came into being Oct. 1, 1991--although it was created on paper July 31--with the near-total transplantation of top researcher Anthony Cerami's group from the Laboratory of Medical Bioc

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Investigations on aging lead the Long Island institute's efforts to combine the best traits of 'pure' and 'applied' research

Just over a year after launch, the Picower Institute for Medical Research in Manhasset, N.Y., is gathering momentum, and confidence among institute researchers is growing. The institute came into being Oct. 1, 1991--although it was created on paper July 31--with the near-total transplantation of top researcher Anthony Cerami's group from the Laboratory of Medical Biochemistry at Rockefeller University, Manhattan, to quarters in the Boas-Marks Biomedical Research Center at North Shore University Hospital, Long Island.

The goal of the Picower is to "apply the insights gained through basic laboratory and clinical research to the discovery of new approaches to curing and preventing disease and improving human health," according to its mission statement. This aim will best be accomplished, say Cerami and the researchers who have joined him, by channeling the institute's efforts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies